Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Peregrine Cotara in Phase IIIAntineoplastic & immunomodulating agents
Gilead Sciences Corus 1030 in Phase IIRespiratory system
Gilead Sciences Corus 1030 in Phase IIRespiratory system
Corcept Therapeutics CORLUX® Phase III initiatedSystemic hormonal preparations
Corcept Therapeutics CORLUX discontinuedNervous system
GlaxoSmithKline Coreg CR Approved in USACardiovascular system
GlaxoSmithKline Coreg Approved in USACardiovascular system
Biovail Coreg Approved in USACardiovascular system
Kyowa Conel Approved in ChinaCardiovascular system
Novartis Comtan Submitted for approval in Japan, approved in EUNervous system
Forest Laboratories Combunox Approved in USANervous system
IDM Pharma Collidem accomplished Phase IAntineoplastic & immunomodulating agents
Adventrx CoFactor in Phase IIIAntineoplastic & immunomodulating agents
Adventrx CoFactor in Phase IIAntineoplastic & immunomodulating agents
UCB Pharma Codeprex Approved in USARespiratory system
AlphaVax CMV and Influenza vaccine in Phase IAnti-infectives for systemic use
Vion Cloretazine in Phase IIIAntineoplastic & immunomodulating agents
Xanthus Clomet in Phase IAntineoplastic & immunomodulating agents
Genzyme CLOLAR Approved in USA, submitted for approval in EUAntineoplastic & immunomodulating agents
Abbott Laboratories Clivarene in Phase IIIBlood & blood forming organs
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.